• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

老年患者中血管紧张素转换酶抑制剂的最佳剂量

Optimal dosage of ACE inhibitors in older patients.

作者信息

Tomlinson B

机构信息

Department of Clinical Pharmacology, Chinese University of Hong Kong, Shatin, Hong Kong.

出版信息

Drugs Aging. 1996 Oct;9(4):262-73. doi: 10.2165/00002512-199609040-00004.

DOI:10.2165/00002512-199609040-00004
PMID:8894524
Abstract

Despite having lower levels of plasma renin activity than younger individuals, elderly patients with hypertension respond well to ACE inhibitors and the drugs have few adverse effects. Plasma concentrations of the active ACE inhibitor are generally higher in the elderly because of decreased renal clearance. These altered pharmacokinetics, combined with impairment of cardiovascular reflexes and the increasing prevalence of heart failure and renal impairment with age, render elderly patients more susceptible to first-dose hypotension. Although many studies have shown that standard dosages are well tolerated it is safer to use lower initial dosages of ACE inhibitors in elderly hypertensive patients because hypotensive reactions are not always predictable. The maintenance dosage may be determined more by the presence of renal disease or heart failure than by age per se. In elderly patients with heart failure, ACE inhibitors should be introduced even more cautiously, using low dosages and preferably under supervision. It may also be necessary to interrupt diuretic treatment for a few days to prevent severe hypotension. The ACE inhibitor dosage should then be titrated up to the maximum that is well tolerated, as this appears to offer the greatest benefit.

摘要

尽管老年高血压患者的血浆肾素活性水平低于年轻人,但他们对ACE抑制剂反应良好,且这些药物几乎没有不良反应。由于肾脏清除率降低,老年患者体内活性ACE抑制剂的血浆浓度通常较高。这些改变的药代动力学,加上心血管反射功能受损以及心力衰竭和肾功能损害的患病率随年龄增加,使老年患者更容易发生首剂低血压。尽管许多研究表明标准剂量耐受性良好,但在老年高血压患者中使用较低的ACE抑制剂初始剂量更安全,因为低血压反应并不总是可预测的。维持剂量可能更多地取决于肾脏疾病或心力衰竭的存在,而不是年龄本身。对于老年心力衰竭患者,应更谨慎地使用ACE抑制剂,采用低剂量,最好在监护下使用。可能还需要中断利尿治疗几天以防止严重低血压。然后应将ACE抑制剂剂量滴定至最大耐受剂量,因为这似乎能带来最大益处。

相似文献

1
Optimal dosage of ACE inhibitors in older patients.老年患者中血管紧张素转换酶抑制剂的最佳剂量
Drugs Aging. 1996 Oct;9(4):262-73. doi: 10.2165/00002512-199609040-00004.
2
Angiotensin II receptor antagonists and heart failure: angiotensin-converting-enzyme inhibitors remain the first-line option.血管紧张素II受体拮抗剂与心力衰竭:血管紧张素转换酶抑制剂仍是一线选择。
Prescrire Int. 2005 Oct;14(79):180-6.
3
Angiotensin converting enzyme inhibitors and moderate hypertension.血管紧张素转换酶抑制剂与中度高血压
Drugs. 1990 Sep;40(3):326-45. doi: 10.2165/00003495-199040030-00002.
4
ACE inhibitors. Differential use in elderly patients with hypertension.血管紧张素转换酶抑制剂。老年高血压患者的差异使用情况。
Drugs Aging. 1995 Nov;7(5):355-71. doi: 10.2165/00002512-199507050-00004.
5
[ACE inhibitors in the treatment of hypertension in elderly patients].
Schweiz Rundsch Med Prax. 1991 Jun 18;80(25):701-6.
6
[Side effects of vasodilator therapy in heart failure: risk of hypotension with ACE inhibitors].[血管扩张剂治疗心力衰竭的副作用:ACE抑制剂引起低血压的风险]
Z Kardiol. 1991;80 Suppl 2:11-5.
7
Angiotensin-converting enzyme inhibitors in the elderly.老年人中的血管紧张素转换酶抑制剂
Am Heart J. 1989 Mar;117(3):751-5. doi: 10.1016/0002-8703(89)90766-7.
8
Optimising ACE inhibitor therapy of congestive heart failure. Insights from pharmacodynamic studies.优化充血性心力衰竭的血管紧张素转换酶抑制剂治疗。药效学研究的见解。
Clin Pharmacokinet. 1993 Jan;24(1):59-70. doi: 10.2165/00003088-199324010-00005.
9
Clinical pharmacokinetics of angiotensin converting enzyme (ACE) inhibitors in renal failure.血管紧张素转换酶(ACE)抑制剂在肾衰竭患者中的临床药代动力学
Clin Pharmacokinet. 1993 Mar;24(3):230-54. doi: 10.2165/00003088-199324030-00005.
10
Age-related effects of angiotensin converting enzyme inhibitors.血管紧张素转换酶抑制剂的年龄相关效应。
J Cardiovasc Pharmacol. 1988;12 Suppl 8:S100-4.

引用本文的文献

1
Beyond the Evidence of the New Hypertension Guidelines. Blood pressure measurement - is it good enough for accurate diagnosis of hypertension? Time might be in, for a paradigm shift (I).超越新高血压指南的证据。血压测量——对于高血压的准确诊断来说足够好吗?是时候进行范式转变了(一)。
Curr Control Trials Cardiovasc Med. 2005 Apr 6;6(1):6. doi: 10.1186/1468-6708-6-6.
2
The Blood Pressure "Uncertainty Range" - a pragmatic approach to overcome current diagnostic uncertainties (II).血压“不确定范围”——克服当前诊断不确定性的实用方法(二)
Curr Control Trials Cardiovasc Med. 2005 Apr 6;6(1):5. doi: 10.1186/1468-6708-6-5.
3

本文引用的文献

1
The effects of age on the pharmacokinetics and pharmacodynamics of single oral doses of benazepril and enalapril.年龄对单次口服苯那普利和依那普利的药代动力学及药效学的影响。
Br J Clin Pharmacol. 1993 Sep;36(3):205-9. doi: 10.1111/j.1365-2125.1993.tb04218.x.
2
A comparison in young and elderly subjects of the pharmacokinetics and pharmacodynamics of single and multiple doses of benazepril.单剂量和多剂量贝那普利在年轻和老年受试者中的药代动力学和药效学比较。
Br J Clin Pharmacol. 1993 Sep;36(3):201-4. doi: 10.1111/j.1365-2125.1993.tb04217.x.
3
A comparison of amlodipine with enalapril in the treatment of isolated systolic hypertension.
[Cardiovascular pharmacotherapy in the aged].
[老年心血管药物治疗]
Internist (Berl). 2003 Aug;44(8):943-50. doi: 10.1007/s00108-003-0939-z.
4
Cardiovascular drug therapy in the elderly: theoretical and practical considerations.老年人的心血管药物治疗:理论与实践考量
Drugs Aging. 2003;20(6):445-63. doi: 10.2165/00002512-200320060-00004.
5
A survey of the dose of ACE inhibitors prescribed by general physicians for patients with heart failure.普通内科医生为心力衰竭患者开具的血管紧张素转换酶抑制剂剂量的调查。
Postgrad Med J. 2001 Dec;77(914):765-8. doi: 10.1136/pmj.77.914.765.
6
Drug selection for optimal treatment of hypertension in the elderly.老年人高血压最佳治疗的药物选择
Drugs Aging. 1997 Jul;11(1):19-26. doi: 10.2165/00002512-199711010-00003.
氨氯地平与依那普利治疗单纯收缩期高血压的比较。
Br J Clin Pharmacol. 1993 May;35(5):499-505. doi: 10.1111/j.1365-2125.1993.tb04176.x.
4
Clinical and neurohumoral response of patients with severe congestive heart failure treated with two different captopril dosages.
Eur Heart J. 1993 Feb;14(2):273-8. doi: 10.1093/eurheartj/14.2.273.
5
Optimising ACE inhibitor therapy of congestive heart failure. Insights from pharmacodynamic studies.优化充血性心力衰竭的血管紧张素转换酶抑制剂治疗。药效学研究的见解。
Clin Pharmacokinet. 1993 Jan;24(1):59-70. doi: 10.2165/00003088-199324010-00005.
6
Single-drug therapy for hypertension in men. A comparison of six antihypertensive agents with placebo. The Department of Veterans Affairs Cooperative Study Group on Antihypertensive Agents.男性高血压的单药治疗。六种抗高血压药物与安慰剂的比较。退伍军人事务部抗高血压药物合作研究组。
N Engl J Med. 1993 Apr 1;328(13):914-21. doi: 10.1056/NEJM199304013281303.
7
Double blind controlled study of low dose intravenous perindoprilat or enalaprilat infusion in elderly patients with heart failure.低剂量静脉注射培哚普利拉或依那普利拉治疗老年心力衰竭患者的双盲对照研究
Br Heart J. 1993 Apr;69(4):293-7. doi: 10.1136/hrt.69.4.293.
8
Pharmacokinetic drug interactions with ACE inhibitors.与血管紧张素转换酶抑制剂的药代动力学药物相互作用。
Clin Pharmacokinet. 1993 Jul;25(1):20-58. doi: 10.2165/00003088-199325010-00003.
9
Antihypertensive efficacy and acceptability of perindopril in elderly hypertensive patients.培哚普利对老年高血压患者的降压疗效及耐受性
Am J Cardiol. 1993 Jun 24;71(17):28E-31E. doi: 10.1016/0002-9149(93)90949-d.
10
Comparison of enalapril versus captopril on left ventricular function and survival three months after acute myocardial infarction (the "PRACTICAL" study).依那普利与卡托普利对急性心肌梗死后三个月左心室功能和生存率影响的比较(“PRACTICAL”研究)
Am J Cardiol. 1994 Jun 15;73(16):1180-6. doi: 10.1016/0002-9149(94)90178-3.